Pharmacology

Interferon-Free Phase II Combination Trial With TMC435 And Daclatasvir

 A phase II interferon-free combination study with TMC435 and daclatasvir will evaluate treatment-naive or previous null responder patients with HCV genotype 1a and 1b- The study will include approx. 180 patients and will evaluate a combination of TMC435 ...

Article - Anna Ohlden - Jun 30 2012 - 5:00am

Positive EC Decision On Flutiform® Combination Therapy For Asthma

Mundipharma today announced the positive European Commission (EC) decision for flutiform(R) (fluticasone propionate/formoterol fumarate), a new combination therapy for the maintenance treatment of asthma, in Europe. This decision is binding on all 21 Conc ...

Article - Anna Ohlden - Jul 3 2012 - 8:50am

Want To Stay Thin? There's A Vaccine For That

A new study has assessed the effectiveness of two somatostatin vaccinations, JH17 and JH18, in reducing weight gain and increasing weight loss in mice. Somatostatin is a peptide hormone which inhibits the action of growth hormone (GH) and insulin-like grow ...

Article - News Staff - Jul 8 2012 - 6:30pm

Ayurvedic Remedy Gets Studied: Frankincense For Asthma?

Science 2.0 fave Dr. Neil deGrasse Tyson recently sent a funny thing across his Twitter feed: Q: What do you call Alternative Medicine that survives double-blind laboratory tests? A: Regular Medicine. And that's the crux of the issue, isn't it?   ...

Article - Hank Campbell - Jul 10 2012 - 5:00am

Phase II Collaborative Study For TroVax In Colorectal Cancer

Oxford BioMedica plc, a gene-based biopharmaceutical company, and Cardiff University announced a Phase II trial to assess the safety and immunological activity of TroVax(R), a therapeutic vaccine for patients with inoperable metastatic colorectal cancer ( ...

Article - Anna Ohlden - Jul 10 2012 - 6:00pm

Janssen Submits Applications Requesting Approval Of SIMPONI® In U.S. And Europe For Treatment Of Ulcerative Colitis

Janssen Biotech, Inc. and Janssen Biologics B.V. announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) requesting appro ...

Article - Anna Ohlden - Jul 16 2012 - 9:28pm

Silymarin: Herbal Remedy For Hepatitis C Does Not Work

Silymarin is an extract of milk thistle. Millions of people use this herbal remedy to treat chronic liver disease but it doesn't do much for patients, according to a new study. Milk thistle fruit extracts have been widely used by patients in treating ...

Article - News Staff - Jul 19 2012 - 12:08pm

Disgruntled OxyContin Addicts Switch To Heroin

Drug addicts are outraged by recent changes to the formula of frequently abused prescription painkiller OxyContin which makes it harder to inhale. So they are taking their business to heroin. For nearly three years, psychiatrists have been collecting infor ...

Article - News Staff - Jul 22 2012 - 3:30am

For The FDA, Biologics In The Balance: Will Cost Saving 'Biosimilars' Undermine Innovation And Patient Safety?

When it comes to new legislation, sometimes what you see is not all you get. Just ask Nancy Pelosi, the House Minority Leader who two years ago uttered the now infamous words, “We have to pass the [Patient Protection and Affordable Health Care Act] so tha ...

Article - Jon Entine - Jul 28 2012 - 1:15am

Emotional Brain Gets Patent For Female Sexual Dysfunction Drug

Emotional Brain has announced that the United States Patent and Trademark Office (USPTO) has awarded a new patent (US Patent No. 8,227,453, issued today) for its combination of a PDE5-inhibitor and testosterone for the treatment of Female Sexual Dysfuncti ...

Article - Anna Ohlden - Jul 24 2012 - 10:18am